Distinguishing Non-Small Cell Lung Adenocarcinoma Patients from Squamous Cell Carcinoma Patients and Control Individuals Using Serum Profiling

被引：6
|
作者：
Hocker, James R. [1 ]
Peyton, Marvin D. [2 ]
Lerner, Megan R. [2 ,3 ]
Lightfoot, Stan A. [3 ,4 ]
Hanas, Rushie J. [1 ]
Brackett, Daniel J. [2 ,3 ]
Hanas, Jay S. [1 ,2 ,3 ]
机构：
[1] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA
[2] Univ Oklahoma, Hlth Sci Ctr, Dept Surg, Oklahoma City, OK 73104 USA
[3] Vet Affairs Med Ctr, Oklahoma City, OK 73104 USA
[4] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA
来源：
CANCER INVESTIGATION | 2012年 / 30卷 / 02期
关键词：
Non-small cell lung cancer; Adenocarcinoma; Squamous cell carcinoma; Serum profiling; Early detection; Predictive value analysis; Electrospray mass spectrometry; OVARIAN-CANCER; IDENTIFICATION; SPECTROMETRY; BIOMARKERS; PROTEOMICS; DISCOVERY;
D O I：
10.3109/07357907.2011.633294
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Goals of this study were to analyze the ability of mass spectrometry serum profiling to distinguish non-small cell lung adenocarcinoma from squamous cell carcinoma patients and healthy controls. Sera were obtained from 19 adenocarcinoma patients, 24 squamous cell carcinoma patients, and 21 controls. Identifications of significant mass-to-charge ratio (m/z) peak differences between these groups were performed using t-tests. A "leave one out" cross-validation procedure yielded discriminatory lung adenocarcinoma versus squamous cell carcinoma p and ROC curve values of < .0001 and 0.92, respectively. Test sensitivity and specificity were 84% and 79%, respectively. This approach could aid in lung cancer diagnosis and sub-typing.
引用
收藏
页码：180 / 188
页数：9
相关论文
共 50 条
  • [31] Histological comparison between preoperative and surgical specimens of non-small cell lung cancer for distinguishing between "squamous" and "non-squamous" cell carcinoma
    Yamagishi, Tomoko
    Shimizu, Katsuhiko
    Ochi, Nobuaki
    Yamane, Hiromichi
    Irei, Isao
    Sadahira, Yoshito
    Takigawa, Nagio
    Oka, Mikio
    Nakata, Masao
    DIAGNOSTIC PATHOLOGY, 2014, 9
  • [32] RELATIONSHIP BETWEEN BONE SERUM MARKERS IN PATIENTS WITH BONE METASTASES FROM NON-SMALL CELL LUNG CARCINOMA
    Loriggiola, Laura
    Lumachi, Franco
    Chiara, Giordano Bruno
    Basso, Stefano Maria Massimiliano
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 : S199 - S199
  • [33] Distinguishing Patients with Stage I Lung Cancer Versus Control Individuals using Serum Mass Profiling
    Hanas, Jay S.
    Peyton, Marvin D.
    Lerner, Megan R.
    Lightfoot, Stan A.
    Deb, Subrato J.
    Hanas, Rushie J.
    Vu, Nicole T.
    Kupiec, Thomas C.
    Stowell, Donald E.
    Brackett, Daniel J.
    Dubinett, Steven M.
    Hocker, James R.
    CANCER INVESTIGATION, 2014, 32 (04) : 136 - 143
  • [34] Protocol for the Examination of Specimens From Patients With Primary Non-Small Cell Carcinoma, Small Cell Carcinoma, or Carcinoid Tumor of the Lung
    Butnor, Kelly J.
    Beasley, Mary Beth
    Cagle, Philip T.
    Grunberg, Steven M.
    Kong, Feng-Ming
    Marchevsky, Alberto
    Okby, Nader T.
    Roggli, Victor L.
    Suster, Saul
    Tazelaar, Henry D.
    Travis, William D.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2009, 133 (10) : 1552 - 1559
  • [35] SURGICAL OUTCOME OF ELDERLY PATIENTS WITH NON-SMALL CELL LUNG CARCINOMA
    Gudbjartsson, Tomas
    Baldvinsson, Kristjan
    Orrason, Andri W.
    Thorsteinsson, Hunbogi
    Sigurdsson, Martin I.
    Jonsson, Steinn
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S517 - S517
  • [36] Management of EGFR mutated non-small cell lung carcinoma patients
    Perquis, M. -P.
    Tissot, C.
    Bouleftour, W.
    Bayle-Bleuez, S.
    Vercherin, P.
    Forest, F.
    Fournel, P.
    REVUE DES MALADIES RESPIRATOIRES, 2022, 39 (09) : 731 - 739
  • [37] Profile of Venous Thromboembolism at the Patients with Non-Small Cell Lung Carcinoma
    Mehic, Bakir
    Zutic, Hasan
    Mehic, Amina
    HEALTHMED, 2009, 3 (01): : 3 - 7
  • [38] Prognostic features in non-small cell lung cancer: difference in metastatic behavior between adenocarcinoma and squamous cell carcinoma
    Usmanij, E. A.
    Posthuma, A.
    Hugen, N.
    van den Ende, R. P. J.
    Nagtegaal, I. D.
    Bussink, J.
    de Geus-Oel, L. F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S674 - S675
  • [39] Outcomes of Patients With Isolated Adrenal Metastasis From Non-Small Cell Lung Carcinoma
    Raz, Dan J.
    Lanuti, Michael
    Gaissert, Henning C.
    Wright, Cameron D.
    Mathisen, Douglas J.
    Wain, John C.
    ANNALS OF THORACIC SURGERY, 2011, 92 (05): : 1788 - 1792
  • [40] A hybrid learning method for distinguishing lung adenocarcinoma and squamous cell carcinoma
    Swain, Anil Kumar
    Swetapadma, Aleena
    Rout, Jitendra Kumar
    Balabantaray, Bunil Kumar
    DATA TECHNOLOGIES AND APPLICATIONS, 2024, 58 (01) : 113 - 131
12345